186 related articles for article (PubMed ID: 20632394)
1. Transcoronary bone marrow-derived progenitor cells in a child with myocardial infarction: first pediatric experience.
Limsuwan A; Pienvichit P; Limpijankit T; Khowsathit P; Hongeng S; Pornkul R; Siripornpitak S; Boonbaichaiyapruk S
Clin Cardiol; 2010 Aug; 33(8):E7-12. PubMed ID: 20632394
[TBL] [Abstract][Full Text] [Related]
2. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
[TBL] [Abstract][Full Text] [Related]
3. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.
Flores-Ramírez R; Uribe-Longoria A; Rangel-Fuentes MM; Gutiérrez-Fajardo P; Salazar-Riojas R; Cervantes-García D; Treviño-Ortiz JH; Benavides-Chereti GJ; Espinosa-Oliveros LP; Limón-Rodríguez RH; Monreal-Puente R; González-Treviño JL; Rojas-Martínez A
Cardiovasc Revasc Med; 2010; 11(2):72-8. PubMed ID: 20347795
[TBL] [Abstract][Full Text] [Related]
5. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
[TBL] [Abstract][Full Text] [Related]
6. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.
Yerebakan C; Kaminski A; Westphal B; Donndorf P; Glass A; Liebold A; Stamm C; Steinhoff G
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1530-9.e3. PubMed ID: 21664627
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up of the local autologous transplantation of CD133+ enriched bone marrow cells in patients with myocardial infarction.
Ahmadi H; Farahani MM; Kouhkan A; Moazzami K; Fazeli R; Sadeghian H; Namiri M; Madani-Civi M; Baharvand H; Aghdami N
Arch Iran Med; 2012 Jan; 15(1):32-5. PubMed ID: 22208441
[TBL] [Abstract][Full Text] [Related]
8. [Autologous stem cell therapy with surgical myocardial revascularization].
Durdu S; Cubukçuoğlu Deniz G; Akar AR
Anadolu Kardiyol Derg; 2009 Dec; 9(6):465-6. PubMed ID: 19965316
[No Abstract] [Full Text] [Related]
9. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
[TBL] [Abstract][Full Text] [Related]
10. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
[TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy.
Ghodsizad A; Ruhparwar A; Marktanner R; Borowski A; Mohammad Hasani MR; Poll L; Vshivkov I; Stoldt V; Voelkel T; Piechaczek C; Burchardt ER; Stockschlaeder M; Sucker C; Gams E; Klein HM
Cytotherapy; 2006; 8(3):308-10. PubMed ID: 16793739
[TBL] [Abstract][Full Text] [Related]
12. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
[TBL] [Abstract][Full Text] [Related]
13. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
14. Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction.
Archundia A; Aceves JL; López-Hernández M; Alvarado M; Rodriguez E; Díaz Quiroz G; Páez A; Rojas FM; Montaño LF
Life Sci; 2005 Dec; 78(3):279-83. PubMed ID: 16183081
[TBL] [Abstract][Full Text] [Related]
15. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
Bartunek J; Vanderheyden M; Vandekerckhove B; Mansour S; De Bruyne B; De Bondt P; Van Haute I; Lootens N; Heyndrickx G; Wijns W
Circulation; 2005 Aug; 112(9 Suppl):I178-83. PubMed ID: 16159812
[TBL] [Abstract][Full Text] [Related]
16. Transcoronary transplantation of progenitor cells after myocardial infarction.
Assmus B; Honold J; Schächinger V; Britten MB; Fischer-Rasokat U; Lehmann R; Teupe C; Pistorius K; Martin H; Abolmaali ND; Tonn T; Dimmeler S; Zeiher AM
N Engl J Med; 2006 Sep; 355(12):1222-32. PubMed ID: 16990385
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Different Bone Marrow-Derived Stem Cell Approaches in Reperfused STEMI. A Multicenter, Prospective, Randomized, Open-Labeled TECAM Trial.
San Roman JA; Sánchez PL; Villa A; Sanz-Ruiz R; Fernandez-Santos ME; Gimeno F; Ramos B; Arnold R; Serrador A; Gutiérrez H; Martin-Herrero F; Rollán MJ; Fernández-Vázquez F; López-Messa J; Ancillo P; Pérez-Ojeda G; Fernández-Avilés F
J Am Coll Cardiol; 2015 Jun; 65(22):2372-82. PubMed ID: 26046730
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium.
Agbulut O; Vandervelde S; Al Attar N; Larghero J; Ghostine S; Léobon B; Robidel E; Borsani P; Le Lorc'h M; Bissery A; Chomienne C; Bruneval P; Marolleau JP; Vilquin JT; Hagège A; Samuel JL; Menasché P
J Am Coll Cardiol; 2004 Jul; 44(2):458-63. PubMed ID: 15261948
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Bhatnagar A; Bolli R; Johnstone BH; Traverse JH; Henry TD; Pepine CJ; Willerson JT; Perin EC; Ellis SG; Zhao DX; Yang PC; Cooke JP; Schutt RC; Trachtenberg BH; Orozco A; Resende M; Ebert RF; Sayre SL; Simari RD; Moyé L; Cogle CR; Taylor DA;
Am Heart J; 2016 Sep; 179():142-50. PubMed ID: 27595689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
